Skip Navigation

Annals of Oncology 2005 16(2):259-262; doi:10.1093/annonc/mdi060
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Luini, A.
Right arrow Articles by Veronesi, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luini, A.
Right arrow Articles by Veronesi, U.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Original article

Development of axillary surgery in breast cancer

A. Luini1,5,*, G. Gatti1,2, B. Ballardini1,2,3, S. Zurrida1, V. Galimberti1, P. Veronesi1, A. R. Vento1, S. Monti1, G. Viale4,5, G. Paganelli6 and U. Veronesi7

1 Division of Breast Surgery, European Institute of Oncology, Milan; 2 Postgraduate School of General Surgery, University of Perugia, Perugia; 3 Division of Breast Surgery, Fondazione Salvatore Maugeri, Pavia; 4 Division of Pathology, European Institute of Oncology, Milan; 5 University of Milan School of Medicine, Milan; 6 Division of Nuclear Medicine, European Institute of Oncology, Milan; 7 European Institute of Oncology, Milan, Italy

* Correspondence to: Dr A. Luini, Director, Division of Breast Surgery, European Institute of Oncology, via G. Ripamonti 435, 20 141 Milan, Italy. Tel: +39-0257-489725; Fax: +39-0257-489780; Email: alberto.luini{at}ieo.it

Axillary surgery is a critical part of the treatment of breast carcinoma: its importance is related to the staging of disease, prescription of adjuvant therapy and prognosis. For years, complete axillary dissection has remained the standard approach to breast cancer lymphatic staging; its value is still high, but the development of sentinel-node biopsy has significantly changed the indication of the procedure. We discuss the evolution of axillary surgery in breast cancer.

Key words: axillary surgery, breast cancer, sentinel node biopsy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
S. B. Edge
Early Adoption and Disturbing Disparities in Sentinel Node Biopsy in Breast Cancer
J Natl Cancer Inst, April 2, 2008; 100(7): 449 - 450.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
N. Duraker, Z. C. Caynak, and B. Bati
Is there any Prognostically Different Subgroup among Patients with Stage IIIC (AnyTN3M0) Breast Carcinoma?
Ann. Surg. Oncol., February 1, 2008; 15(2): 430 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Tsujimoto, K. Nakabayashi, K. Yoshidome, T. Kaneko, T. Iwase, F. Akiyama, Y. Kato, H. Tsuda, S. Ueda, K. Sato, et al.
One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients
Clin. Cancer Res., August 15, 2007; 13(16): 4807 - 4816.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.